Peripheral Nerve Disorders

Published on 03/03/2015 by admin

Filed under Neurology

Last modified 03/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3038 times

Chapter 5 Peripheral Nerve Disorders

By relying on clinical findings, physicians can distinguish peripheral nervous system (PNS) from central nervous system (CNS) disorders. In PNS disorders, damage to one, a group, or all peripheral nerves causes readily observable patterns of paresis, deep tendon reflex (DTR) loss, and sensory impairments. Some PNS disorders are characteristically associated with mental changes, systemic illness, or a fatal outcome.

Anatomy

The spinal cord’s anterior horn cells form the motor neurons of the peripheral nerves – the PNS’ starting point. The peripheral nerves are the final link in the neuron chain that transmits motor commands from the brain through the spinal cord to muscles (Fig. 5-1). Nerve roots emerging from the anterior spinal cord mingle within the brachial or lumbosacral plexus to form the major peripheral nerves, such as the radial and femoral. Although peripheral nerves are quite long, especially in the legs, they faithfully conduct electrochemical impulses over considerable distances. Because myelin, the lipid-based sheath generated by Schwann cells, surrounds peripheral nerves and acts as insulation, the impulses are preserved.

image

FIGURE 5-1 The corticospinal tracts, as discussed in Chapter 2, and as their name indicates, consist of upper motor neurons (UMNs) that travel from the motor cortex to the spinal cord. They synapse on the spinal cord’s anterior horn cells, which give rise to the lower motor neurons (LMNs). The LMNs join sensory fibers to form peripheral nerves.

When stimulated, motor nerves release packets of acetylcholine (ACh) from storage vesicles at the neuromuscular junction. The ACh packets traverse the junction and bind on to specific ACh receptors on the muscle end plate. The interaction between ACh and its receptors depolarizes the muscle membrane and initiates a muscle contraction (see Chapter 6). Neuromuscular transmission culminating in muscle depolarization is a discrete, quantitative action: ACh does not merely seep out of the presynaptic terminal as loose molecules and drift across the neuromuscular junction to trigger a muscle contraction.

Peripheral nerves also transmit sensory information, but in the reverse direction: from the PNS to the CNS. For example, pain, temperature, vibration, and position receptors – which are located in the skin, tendons, and joints – send impulses through peripheral nerves to the spinal cord.

Mononeuropathies

Disorders of single peripheral nerves, mononeuropathies, are characterized by flaccid paresis, DTR loss (areflexia), and reduced sensation, particularly for pain (hypalgesia [Greek, hypo, under + algos, pain] or analgesia [Greek, insensitivity to pain]) (Table 5-1). Paradoxically, mononeuropathies and other peripheral nerve injuries sometimes lead to spontaneously occurring sensations, paresthesias (Greek para, near + aisthesis, sensation) that may be painful, dysesthesias. Peripheral nerve injuries also convert stimuli that ordinarily do not cause pain, such as a light touch or cool air, into painful sensations, allodynia; exaggerate painful responses to mildly noxious stimuli, such as the point of a pin, hyperalgesia; or delay but then exaggerate and prolong pain from noxious stimuli, hyperpathia.

Several mononeuropathies are common, important, and readily identifiable. They usually result from penetrating or blunt trauma, compression, diabetic infarctions, or other damage to single nerves.

Compression, especially of nerves protected only by overlying skin and subcutaneous tissue rather than by bone, viscera, or thick layers of fat, occurs frequently. People most susceptible are diabetics; those who have rapidly lost weight, thereby depleting nerves’ protective myelin covering; workers in certain occupations, such as watchmakers; and those who have remained in disjointed positions for long periods, often because of drug or alcohol abuse. One of the most common compressive mononeuropathies – “Saturday night palsy” – affects the radial nerve, which is vulnerable at the point where it winds around in the spiral groove of the humerus. Thus, people in alcohol-induced stupor who lean against their upper arm for several hours are apt to develop a wrist drop (Fig. 5-2). Foot drop, its lower-extremity counterpart, often results from common fibular nerve* damage from prolonged leg crossing compressing the nerve, lower-knee injuries traumatizing the nerve, or a constrictive lower-leg cast pushing against the nerve as it winds around the head of the fibula.

Carpal tunnel syndrome, the most common mononeuropathy, results from damage of the median nerve as it travels through the carpal tunnel of the wrist (Fig. 5-3, left). Forceful and repetitive wrist movements can traumatize the nerve in that confined passage. Meat and fish processing, certain assembly-line work, and carpentry are all closely associated with carpal tunnel syndrome; however, contrary to initial claims, word processing and other keyboarding actually have a weak association with the disorder. In another mechanism, fluid retention during pregnancy or menses entraps the median nerve in the carpal tunnel. Similarly, inflammatory tissue changes in the wrist from rheumatoid arthritis may compress the median nerve.

Whatever the mechanism, carpal tunnel syndrome causes paresthesias and pains that shoot from the wrist to the palm, thumb, and adjacent two or sometimes three fingers (Fig. 5-3, right). Symptoms worsen at night and awaken the victims, who shake their hands in an attempt to find relief. Neurologists test for the syndrome’s characteristic Tinel sign by percussing the wrist: The test is positive when the percussion generates electric sensations that shoot from the wrist into the palm and fingers.

With chronic carpal tunnel syndrome, median nerve damage leads to thenar (thumb) muscle weakness and atrophy. It also leads to impaired fine movements of the thumb and adjacent two fingers, which are instrumental in precision movements, such as writing, grasping small objects, and closing buttons.

Most carpal tunnel syndrome patients respond to rest and, sometimes, splints. Diuretics and anti-inflammatory drugs are also helpful. In refractory cases, a surgeon might inject steroids into the carpal tunnel or resect the transverse carpal ligament to decompress the tunnel.

In another example of upper-extremity nerve damage, pressure on the ulnar groove of the elbow (the “funny bone”) or cubital tunnel may damage the ulnar nerve. For instance, when individuals rest the weight of their arms on their elbows, the compression often injures the ulnar nerve. These individuals develop atrophy and weakness of their hand muscles (Fig. 5-4). The ulnar nerve damage also leads to loss of sensation of the fourth and fifth fingers and the medial surface of the hand.

Mononeuropathies can result from systemic illnesses, such as diabetes mellitus, vasculitis (e.g., lupus erythematosus, polyarteritis nodosa), and lead intoxication (see later) – as well as from trauma. In most of the systemic conditions, pain, weakness, and other symptoms have an abrupt onset. In addition, systemic illnesses often cause stroke-like CNS insults along with the mononeuropathies.

Polyneuropathies (Neuropathies)

The most frequently occurring PNS disorder, polyneuropathy or simply neuropathy, is generalized, symmetric involvement of all peripheral nerves. Some neuropathies also attack cranial nerves. Neurologists may divide neuropathies into those that predominantly damage either the myelin (demyelinating neuropathies) or axons (axonopathies). Most cases of demyelinating neuropathies fall into the category of inflammatory illness; however, cases of axonopathy include ones from porphyria, toxins, metabolic illnesses, and nutritional deficiencies. Although psychiatrists should be aware of that distinction, they must concentrate on neuropathies associated with mental status changes.

Alternatively, neurologists divide neuropathies into sensory, motor, or mixed sensorimotor neuropathy. Patients with sensory neuropathy usually suffer predominantly or exclusively from numbness, paresthesias, or burning in their fingers and toes (i.e., stocking-glove hypalgesia: Fig. 5-5). The pain may reach intolerable proportions (see neuropathic pain, Chapter 14). When sensory neuropathy affects the feet, it may provoke leg movements, such as restless legs syndrome (see Chapter 17). Patients with motor neuropathy usually have distal limb weakness that impairs fine, skilled hand and finger movements, such as buttoning a shirt, or raising their feet when they walk, which causes a foot drop. Their neuropathy in chronic cases usually also leads to muscle atrophy and flaccidity. As with other LMN injuries, it diminishes DTRs (see Fig. 2-2C), first at the brachioradialis and Achilles’ and then at more proximal sites. Mixed sensorimotor neuropathy causes mixtures of those symptoms and signs.

Neurologists who care for psychiatric patients may meaningfully divide neuropathies into those with and those without comorbid changes in mental status (Box 5-1).

Neuropathies Without Comorbid Mental Status Changes

Guillain–Barré Syndrome

Acute inflammatory demyelinating polyradiculoneuropathy or postinfectious demyelinating polyneuropathy, commonly known as Guillain–Barré syndrome, is both the quintessential PNS illness and the primary example of a demyelinating neuropathy. Although often idiopathic, this syndrome typically follows an upper respiratory or gastrointestinal illness. Cases following a week’s episode of watery diarrhea are apt to be associated with a gastrointestinal Campylobacter jejuni infection and be more extensive and severe than idiopathic cases. Many cases seem to be a complication of other infectious illnesses, including human immunodeficiency virus (HIV) infection, Lyme disease, mononucleosis, hepatitis, cytomegalovirus, and West Nile virus. Although Guillain–Barré syndrome followed administration of older influenza vaccinations, it has not complicated administration of the current ones.

When first affected, young and middle-aged adults feel paresthesias and numbness in the fingers and toes. Then they develop flaccid paresis of their feet and legs with characteristically absent knee and ankle DTRs. Weakness and areflexia, which soon become a much greater problem than numbness, ascend to involve the hands and arms. Many patients progress to respiratory insufficiency because of involvement of the phrenic and intercostal nerves, and require intubation for ventilation. If weakness ascends still further, patients develop cranial nerve involvement that may lead to dysphagia and other aspects of bulbar palsy (see Chapter 4). Additional involvement causes facial weakness and then sometimes even ocular immobility. Nevertheless, possibly because optic and acoustic nerves are protected by myelin generated by the CNS – not the PNS – patients continue to see and hear.

Even if the illness worsens to the point of total paralysis, patients usually remain conscious with a normal mental status – allowing for anxiety and depressive symptoms from enduring a life-threatening illness. Completely immobile and anarthric Guillain–Barré syndrome patients, typically with preserved consciousness and mental status, exist in a locked-in syndrome (see Chapter 11). Cerebrospinal fluid (CSF) exhibits an elevated protein concentration but with few white cells (i.e., the classic albumino-cytologic dissociation) (see Table 20-1).

The illness usually resolves almost completely within 3 months as the PNS myelin is regenerated. By way of treatment, plasmapheresis (plasma exchange), which extracts circulating inflammatory mediators, particularly autoantibodies, complement, and cytokines, reduces the severity and duration of the paresis. Alternatively, administration of intravenous human immunoglobulin, which “blocks” the antibodies at the neuromuscular junction, also restores patients’ strength. Steroids will not help, which is surprising because they are helpful in other inflammatory diseases of the nervous system, such as myasthenia gravis (see Chapter 6), multiple sclerosis (MS: see Chapter 15), and the chronic form of Guillain–Barré syndrome (chronic inflammatory demyelinating polyneuropathy).

Not only is Guillain–Barré syndrome a life-threatening illness, but it also epitomizes the distinction between PNS and CNS diseases. Although paraparesis or quadriparesis might be a feature common to PNS and CNS illnesses, different patterns of muscle weakness, changes in reflexes, and sensory distribution characterize PNS and CNS illnesses (Table 5-2). Also, in Guillain–Barré syndrome, as in most neuropathies other than diabetic neuropathy (see later), bladder, bowel, and sexual functions are preserved. In contrast, patients with spinal cord disease usually have incontinence and impotence at the onset of the injury.

TABLE 5-2 Differences between Central (CNS) and Peripheral Nervous System (PNS) Signs

  CNS PNS
Motor System Upper motor neuron Lower motor neuron
Paresis Patterns* Distal
Tone Spastic Flaccid
Bulk Normal Atrophic
Fasciculations No Sometimes
Reflexes    
Deep tendon reflexes Hyperactive Hypoactive
Plantar Babinski sign(s) Absent
Sensory loss Patterns* Hands and feet

*Examples: motor and sensory loss of one side or lower half of the body (e.g., hemiparesis or paraparesis), and hemisensory loss.

May be flaccid initially.

May be absent initially.

Another contrast arises from the difference between demyelinating diseases of the CNS and PNS. Despite performing a similar insulating function, CNS and PNS myelin differ in chemical composition, antigenicity, and cells of origin. Oligodendrocytes produce CNS myelin, and Schwann cells produce PNS myelin. In other words, oligodendrocytes are to Schwann cells as the CNS is to the PNS. Also, each oligodendrocyte produces myelin that covers many nearby CNS axons, but each Schwann cell produces myelin that covers only one portion of a single PNS axon. From a clinical viewpoint, Schwann cells regenerate damaged PNS myelin and thus Guillain–Barré patients usually recover. In contrast, because oligodendrocytes do not regenerate damaged CNS myelin, impairments are permanent in patients who have lost CNS myelin to toxins and infections. For example, the CNS demyelination that results from toluene use represents a permanent loss.

MS appears to be a partial exception to the rule that CNS demyelinating damage is permanent. In MS, episodes of demyelination of several CNS areas, including the optic nerves, partially or even completely resolve (see Chapter 15). However, the improvement results from resolution of myelin inflammation rather than myelin regeneration. When MS-induced demyelination eventually encompasses large areas of cerebral CNS myelin, it results in permanent quadriparesis and dementia.

From another perspective, patients with uncomplicated cases of Guillain–Barré syndrome, despite profound motor impairment, should not have an altered mental status because it is a disease of the PNS. Thus, when Guillain–Barré syndrome patients develop mental changes, consulting physicians should look for complications involving the CNS, particularly cerebral hypoxia from respiratory insufficiency, “steroid psychosis” from high-dose steroid treatment (now outdated), hydrocephalus from impaired reabsorption of CSF that has an elevated protein concentration, hyponatremia from inappropriate antidiuretic hormone secretion, or sleep deprivation. Guillain–Barré syndrome patients with the most pronounced impairments – quadriparesis, dependency on artificial ventilation, and multiple cranial nerve involvement – are the ones most apt to experience a psychotic episode.

Thus, psychiatric consultants should look first for hypoxia and other life-threatening medical complications in Guillain–Barré patients who develop mental aberrations. Also, unless the patient is already on a respirator, psychiatrists should avoid prescribing medications, such as benzodiazepines and certain antipsychotics, that depress respirations.

Diabetes

Although rigid treatment of diabetes may delay or even prevent diabetic neuropathy, most patients who have diabetes for more than 10 years show its symptoms and signs. In addition, risk factors for vascular disease, such as obesity and cigarette smoking, exacerbate the neuropathy.

The classic finding is loss of sensation in a stocking-glove distribution. Strength remains relatively normal, but patients lose the DTRs in their ankles, then knees. With long-standing diabetic neuropathy, impaired sensation in their fingertips prevents blind diabetic patients from reading Braille. In addition to the distal symmetric sensory loss, diabetic patients may suffer from suddenly occurring painful mononeuropathies and mononeuritis multiplex or continuous intense burning sensations, especially in the feet. These sensations are especially distressing at night and prevent sleep. By a different mechanism – damaging blood vessels – diabetes can lead to cerebrovascular disease that eventually may cause multi-infarct (vascular) dementia.

Three groups of medicines suppress the pain of diabetic neuropathy and other neuropathies. Narcotics (opioids), but not less potent analgesics, help. Certain antiepileptic drugs (AEDs), such as gabapentin (Neurontin) and pregabalin (Lyrica), reduce pain and promote sleep. The third group, tricyclic antidepressants, in doses too low to relieve depression, reduce pain and promote sleep. Although selective norepinephrine reuptake inhibitors, such as duloxetine (Cymbalta), also help, selective serotonin reuptake inhibitors do not. In an alternative approach, a skin cream containing capsaicin, which depletes substance P, the putative neurotransmitter for pain, provides some analgesia, along with numbness, to limited areas. In contrast to their usefulness in most painful conditions, nonsteroidal anti-inflammatory drugs provide little benefit in diabetic neuropathy.

Patients with diabetic neuropathy may also have autonomic nervous system involvement that causes gastrointestinal immobility, bladder muscle contraction, and sexual dysfunction. In fact, erectile dysfunction is occasionally the first or most disturbing symptom of diabetic autonomic neuropathy (see Chapter 16).

Toxic-Metabolic Disorders

Numerous toxins, metabolic derangements, and medications frequently cause neuropathy. For example, renal insufficiency (uremia) is a common cause of neuropathy that occurs almost universally in patients undergoing maintenance hemodialysis. Also, cancer chemotherapy agents and antibiotics, including those for tuberculosis and HIV disease (see later), routinely cause neuropathy; however, antipsychotics, antidepressants, and AEDs, except for phenytoin, do not. When medications, chemicals, or other substances cause CNS or PNS damage, neurologists label them neurotoxins.

Several heavy metals cause combinations of PNS and CNS impairments. For example, lead poisoning causes a neuropathy in adults and other problems in children. Pica (craving for unnatural foods), mostly from hunger, in young children prompts them to eat lead pigment paint chips from toys or decaying tenement walls. (Lead paint on interior walls has been illegal in most cities for decades.) Even at low concentrations, lead is neurotoxic in children. Lead ingestion is associated with inattention, learning disabilities, and poor school performance. High serum concentrations are associated with seizures and mental retardation. Because lead has a different deleterious effect on the mature nervous system, adults with lead poisoning develop mononeuropathies, such as a foot drop or wrist drop, rather than cerebral impairments. Adults most often develop lead poisoning from industrial exposure, drinking homemade alcohol distilled in equipment with lead pipes (“moonshine”), or burning car batteries for heat.

Chronic, low-level intoxication by several other heavy metals causes polyneuropathy, dermatologic abnormality, and mental changes. In contrast, acute heavy metal poisoning typically leads to fatal gastrointestinal symptoms and cardiovascular collapse. Arsenic, which is tasteless and odorless, is a poison used in popular murder cases. With chronic, low-level, deliberate, accidental, or industrial intoxication, arsenic causes anorexia, malaise, and a distal neuropathy that might mimic Guillain–Barré syndrome. It also causes several characteristic dermatologic abnormalities: Mees lines on the fingernails (Fig. 5-6), hyperpigmentation, and hyperkeratosis.

Mercury intoxication is more complex than arsenic poisoning. Individuals with mercury poisoning may develop a neuropathy and various CNS deficits, including cognitive impairment, ataxia, dysarthria, and visual field changes. Their gums accumulate a telltale dark line just below their teeth (Fig. 5-7).

Organic mercury compounds, such as methylmercury, typically enter the food chain at the lowest level and progress upward to saturate edible fish. Pregnant women who consume even modest quantities of mercury-containing food place their fetus at risk of mental retardation. Fish highest on the food chain carry the highest mercury concentrations. Thus, the fish group with the highest concentrations includes tuna (white meat), swordfish, and Chilean sea bass; the next highest, bluefish, halibut, and striped bass; the next highest, sole; and the lowest, herring and sardines.

Poisoning with inorganic mercury, widely used in industry, causes kidney damage, but only mild cognitive impairment. Studies have not established definitively safe environmental or workplace levels.

Investigators at one time proposed that mercury-based dental amalgams (“fillings”) caused Alzheimer disease and other neurodegenerative illnesses either by dissolving in saliva and allowing mercury to enter the circulation or emitting a mercury vapor those individuals inhaled. In another inquiry, because ethyl mercury was a major component of the common vaccine preservative, thimerosal, investigators suspected that routine childhood immunizations caused autism (see Chapter 13). However, statistically powerful epidemiologic studies disproved both of those suspicions. In the case of vaccinations, the original “investigators” possibly engaged in fraud.

Thallium, another heavy metal, is the active ingredient of many rodenticides. Murderers, at least in mystery novels, lace food with it. Like other chronic heavy metal intoxications, chronic thallium intoxication causes a neuropathy that might be painful. The clue to thallium poisoning is hair loss (alopecia).

Neuropathies With Comorbid Mental Status Changes

Although most neuropathies, as described in the previous section, may be painful, incapacitating, or even devastating to the PNS, they generally do not cause mental changes in adults. For example, most people who are old, diabetic, on hemodialysis, or receiving chemotherapy remain intelligent, thoughtful, and competent even though beset by pain, sensory loss, and weakness. In contrast, only a few diseases (see Box 5-1) cause the combination of dementia and neuropathy, which would indicate both cerebral cortex and peripheral nerve damage. An analogous combination would be dementia and movement disorders, which would indicate cerebral cortex and basal ganglia damage (see Box 18-4).

Nutritional Deficiencies

Deficiencies of thiamine (vitamin B1), niacin (nicotinic acid, B3), or vitamin B12 (cobalamine), each produce a predominantly sensory neuropathy accompanied by dementia or other mental status abnormality (Table 5-3). From a worldwide perspective, starvation has been the most common cause of deficiencies of vitamins, their carrier fats, minerals, and other nutrients. For example, beriberi was the starvation-induced neuropathy attributable to thiamine deficiency endemic in eastern Asia. In the United States, alcoholism, bariatric surgery, and malabsorption syndromes have replaced starvation as the most common causes of nutritional neuropathies. Curiously, few patients with anorexia nervosa or self-imposed extreme diets develop a neuropathy. Their protection may lie in a selective, possibly secret, intake of food or vitamins.

Bariatric surgery remains a unique example. After its rapid introduction and widespread acceptance, postoperative “micronutrient” deficiencies caused various neurologic illnesses. Thiamine, copper, and vitamins B12 and E deficiencies frequently caused neuropathy, but also occasionally encephalopathy or myelopathy (see Chapter 4), i.e., CNS problems. Routine postoperative administration of these micronutrients has prevented the problem.

Alcohol-induced neuropathy has been virtually synonymous with thiamine deficiency because most cases are found in alcoholics who typically subsist on alcohol and carbohydrate-rich foods devoid of thiamine. Nevertheless, alcohol and thiamine deficiency may not be the only culprits. Studies have shown that alcohol itself did not cause a neuropathy and that thiamine deficiency is not present in all cases of this neuropathy.

Whatever the cause, thiamine deficiency generally leads to absent DTRs and loss of position sensation. In fact, until patients walk in the dark, when they must rely on position sense generated in the legs and feet, their deficits may remain asymptomatic. In the well-known Wernicke–Korsakoff syndrome, amnesia, dementia, and cerebellar degeneration accompany the neuropathy associated with alcoholism (see Chapter 7).

In another example of vitamin deficiency causing neuropathy, niacin deficiency is associated with or causes pellagra (Italian, rough skin). This starvation-induced disorder consists of dementia, dermatitis, and diarrhea – the “three Ds.” Despite pellagra’s status as a classic illness, the role of niacin deficiency has been challenged: deficiencies of other nutrients either coexist with or are more likely to be the actual cause.

Among its many functions, vitamin B12 sustains both CNS and PNS myelin. Thus, B12 deficiency leads to the combination of CNS and PNS damage – combined system disease. Although its manifestations include a neuropathy, cognitive impairment and sensory loss reflecting demyelination of the posterior columns of the spinal cord (see Fig. 2-19B) predominate. Patients also develop a characteristic megaloblastic anemia. Most importantly, neurologists refer to combined system disease as a “correctable cause of dementia” because B12 injections can reverse the cognitive impairment as well as the other CNS and PNS manifestations. The usual causes of B12 deficiency include pernicious anemia, malabsorption, a pure vegetarian diet, or prolonged exposure to nitrous oxide, a gaseous dental anesthetic. (Nitrous oxide inactivates B12 by oxidizing its cobalt.)

The screening test for B12 deficiency consists of determining the serum B12 level. In equivocal cases, especially when cognitive impairment or spinal cord abnormalities are not accompanied by anemia, determining the serum homocysteine and methylmalonic acid levels can corroborate the diagnosis: in B12 deficiency, both homocysteine and methylmalonic acid levels rise to abnormally high levels (Fig. 5-8). Intrinsic factor antibodies, a classic finding in pernicious anemia, will be detectable in only about 60% of cases. The standard confirmatory test is the Schilling test.

A variation on nutritional deficiencies causing neuropathy is celiac disease. In this condition, foods containing wheat gluten or similar protein constituents of rye and barley trigger an immune response. Affected individuals develop not only malabsorption, which is not always readily apparent, but also neuropathy and sometimes ataxia. Severely affected ones develop osteoporosis, cardiac disease, and cancer.

In contrast to malnutrition causing neuropathy, excessive intake of certain vitamins causes neurologic problems. For example, although the normal adult daily requirement of vitamin B6 (pyridoxine) is only 2–4 mg daily, several food faddists who consumed several grams daily as part of a special diet developed a profound sensory neuropathy. Similarly, high vitamin A intake may cause pseudotumor cerebri (see Chapter 9) or induce fetal abnormalities (see Chapter 13).

Infectious Diseases

Several common organisms have a predilection for infecting the peripheral nerves and sparing the CNS. For example, herpes zoster infects a single nerve root or a branch of the trigeminal nerve, usually in people older than 65 years or those with an impaired immune system. An infection with herpes (Greek, herpes, spreading skin eruption) causes an ugly, red, painful, vesicular eruption (“shingles”) that may remain excruciating long after the skin infection has resolved (see postherpetic neuralgia, Chapter 14). As another example, leprosy (Hansen disease), infection with Mycobacterium leprae, causes anesthetic, hypopigmented patches of skin, anesthetic fingers and toes, and palpable nerves. It particularly affects the cool portions of the body, such as the nose, earlobes, and digits; however, depending on its variety, the infection strikes the ulnar or another large nerve either singly or along with others.

Some infections involve the CNS as well as the PNS. Named for the town in Connecticut where it was discovered, Lyme disease has risen to endemic levels in New England, Westchester, eastern Long Island, Wisconsin, Minnesota, and the Pacific Northwest. Infection by Borrelia burgdorferi, a spirochete whose vector is a certain tick, causes Lyme disease. The illness’ peak incidence occurs in June through September, when people spend time in tick-infested wooded areas.

Acute Lyme disease typically produces multiple problems, such as arthritis, malaise, low-grade fever, cardiac arrhythmias, and a pathognomonic bull’s-eye-shaped expanding rash, erythema migrans (Greek, erythema, flush + migrans, move), surrounding the tick bite. In addition, Lyme disease frequently causes a facial nerve paresis, similar to Bell’s palsy, either unilaterally or bilaterally (see Fig. 4-15). Its PNS manifestations range from a mild neuropathy causing only paresthesias to a severe Guillain–Barré-like illness.

With CNS involvement, patients typically have headache, delirium (see Chapter 7), and other signs of meningitis or encephalitis. Their CSF may show a pleocytosis, elevated protein, decreased glucose concentrations, and Lyme antibodies. Serologic tests for Lyme disease remain unreliable. Another confusing aspect of the diagnosis is that patients may have a biologic false-positive test for syphilis because B. burgdorferi is a spirochete (see Chapter 7).

Numerous individuals and physicians attribute years of symptoms – cognitive impairment, weakness, fatigue, and arthralgias – after an attack of adequately treated Lyme disease to a persistent Lyme infection or disordered immunologic response to it. This condition, “chronic Lyme disease,” meets with skepticism in the neurologic community because it lacks consistent clinical criteria, pathology, and test results. Moreover, chronic Lyme disease symptoms do not respond to additional antibiotic treatment (see Chapters 6 and 7).

Even though Lyme disease is common, the most widespread infection of the CNS and PNS is acquired immunodeficiency syndrome (AIDS). Although direct HIV infection probably causes neuropathy associated with AIDS, alternative potential etiologies include opportunistic infectious agents and HIV medicines, such as nucleoside reverse transcriptase inhibitors (ddI [didanosine, Videx] and ddC [zalcitabine]). AIDS-associated peripheral nerve disorder usually develops insidiously and consists of distal, symmetrical painful dysesthesias, which can be agonizing, and numbness of the soles of the feet. In contrast to the pronounced sensory symptoms, the motor symptoms consist of only relatively mild ankle and foot weakness with loss of ankle DTRs.

HIV-associated polyneuropathy generally develops late in the course of the illness when many other problems overshadow it. By then, the plasma HIV RNA titer is elevated and the CD4 count is low. In addition, depression and decreased physical function have supervened. Treatments for diabetic neuropathy often ameliorate the pain of AIDS neuropathy.

Inherited Metabolic Illnesses

Although numerous genetically determined illnesses cause neuropathy, two also cause psychosis.

Acute intermittent porphyria (AIP), the classic autosomal dominant genetic disorder of porphyrin metabolism, causes dramatic attacks of quadriparesis and colicky, often severe, abdominal pain. In about 25–50% of attacks, AIP patients develop any of a variety of psychiatric symptoms, including agitation, delirium, depression, and psychosis. During attacks, excess porphyrins color the urine red. Quantitative tests, which replace the classic Watson–Schwartz test, readily detect urinary porphobilinogen and 5-aminolevulinic acid in urine and serum. Although barbiturates and phenytoin may exacerbate an attack, phenothiazines are relatively safe. Notwithstanding its prominence as a standard examination question, AIP is rare in the United States.

Metachromatic leukodystrophy (MLD), an autosomal recessive illness carried on chromosome 22, derives its name from the colored granules (lipid sulfatides) that accumulate in the lysosomes of the brain, peripheral nerves, and many nonneurologic organs, such as the gallbladder, pancreas, and liver. Most importantly, MLD, like MS, causes a demyelination process in the CNS white matter (leukodystrophy) and, to a lesser extent, the PNS (see Chapter 15).

MLD symptoms usually first appear in infants and children, in whom the illness pursues a rapidly fatal course. In young adults, MLD presents with personality and behavioral changes, thought or mood disorder, and cognitive impairment. MLD-induced cognitive impairments typically progress slowly to dementia. Neurologists describe MLD-induced cognitive impairment as a “frontal dementia” because of its combination of personality, behavioral, and cognitive manifestations (see Chapter 7). Peripheral neuropathy and signs of CNS demyelination – spasticity and ataxia – follow and eventually overshadow the frontal dementia.

Buy Membership for Neurology Category to continue reading. Learn more here